Drugs Acting on Blood Coagulation: Anticoagulants and Fibrinolytics
1. Blood Coagulation Process:
- When bleeding occurs, the body responds by:
- Vasoconstriction: Reducing blood flow.
- Platelet Plug Formation: Platelets adhere to the wound, forming a temporary seal.
- Fibrin Formation: Fibrin strands connect to the platelet plug, creating a stable blood clot.
2. Drugs Affecting Blood Coagulation:
- Coagulants:
- Vitamin K (K-drugs):
- Mechanism: Vitamin K activates coagulation factors II, VII, IX, and X.
- Indications: Premature infants, miscarriage, frequent diarrhea, individuals with bile acid-related diseases.
- Route of administration: Oral, intravenous injection.
- Antiplatelet Drugs:
- Mechanism: Inhibit platelet activation, preventing platelet plug formation.
- Types:
- Thromboxane A2 inhibitors: Aspirin.
- ADP inhibitors: Clopidogrel, ticlopidine, prasugrel, ticagrelor.
- GP IIb/IIIa inhibitors: Abciximab (used in emergencies), eptifibatide, tirofiban.
- PDE enhancers: Dipyridamole.
- Vasodilator in the occluded area: Cilostazol.
- ADRs:
- Aspirin: Gastric ulceration, diarrhea, elevated liver enzymes.
- Anticoagulants:
- Mechanism: Inhibit fibrin formation, reducing blood coagulation ability.
- Types:
- Thrombin IIa inhibitors:
- Indirect: Heparin (intravenous injection, subcutaneous injection), fondaparinux (intravenous injection, subcutaneous injection).
- Direct: Hirudin (injection), dabigatran (oral).
- Xa inhibitors:
- Indirect: Low-dose heparin, idaparinux, fondaparinux (intravenous injection, subcutaneous injection).
- Direct: Rivaroxaban, apixaban, edoxaban (oral).
- Vitamin K antagonist anticoagulants: Warfarin, dicumarol.
- ADRs:
- Heparin: Thrombocytopenia, osteoporosis, bleeding.
- Warfarin: Bleeding, drug interactions, contraindicated in pregnancy, individuals using artificial heart valves.
- Principles of Anticoagulation: Cutting a coagulation factor or removing calcium (outside the body).
- Fibrinolytics:
- Mechanism: Dissolve pre-formed blood clots.
- Types:
- Non-selective fibrinolytic agents: Streptokinase, urokinase.
- Non-heterologous fibrinolytic agents: Urokinase.
- Selective fibrinolytic agents: Alteplase, reteplase, tenecteplase.
- ADRs:
- Streptokinase: Heterologous shock, widespread bleeding.
3. Summary:
Drugs acting on the blood coagulation process come in many types, each with a different mechanism of action, used in different pathological conditions. The use of these drugs must be prescribed by a specialist to ensure safety and effectiveness.
Leave a Reply